Fig. 8
From: Cell senescence-associated genes predict the malignant characteristics of glioblastoma
The pan-cancer analysis of 32 types of tumors and the drug sensitivity. Tumor mutation burden (TMB) A, microsatellite instability (MSI) B, and CD274 C of 32 types of tumors. D Survival analysis of the low- and high-risk score patient groups based on the IMvigor210 cohort. E The percentage of immunotherapy response and immunophenotype in high and low-risk scores. F The Kaplan-Meier test of GBM patients receiving ICB therapy by risk score combining tumor neoantigen burden. E Assessing drug sensitivity of GBM tumor based on the risk score. F Signal paths are targeted by drug sensitivity with the risk score. Blue (positive correlation) or red (negative correlation)